Rapid Diagnostic Kits Market for Indian Ocean Region Countries (France, India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar) by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospital, Diagnostic Lab) - Forecast to 2029
Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic Labs)—Forecast to 2029
The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.
Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.
The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.
Based on product, in 2022, the professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to increasing hospitalizations, the high prevalence of chronic diseases such as cancer and cardiac conditions, the advantages of rapid diagnostic kits over laboratory tests, including low cost and low turnaround time, and their gradual increase in the use.
Based on platform, in 2022, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.
Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. The high prevalence and outbreaks of infectious diseases and the high adoption of self-testing kits for infectious diseases are primary factors supporting the large market share of this segment.
Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. Factors attributing to this segment's growth include increasing hospitalizations due to various diseases, the increasing geriatric population, and increased healthcare access & expenditure.
An in-depth analysis of the geographical scenario of the rapid diagnostic kits market for Indian Ocean region countries provides detailed qualitative and quantitative insights about the major geographies (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, R?union, Comoros, Mayotte, and Seychelles). France is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022, followed by India, Australia, Indonesia, and Singapore.
Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioM?rieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Scope of the Report
Scope of the Report
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography
The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.
Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.
The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.
Based on product, in 2022, the professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to increasing hospitalizations, the high prevalence of chronic diseases such as cancer and cardiac conditions, the advantages of rapid diagnostic kits over laboratory tests, including low cost and low turnaround time, and their gradual increase in the use.
Based on platform, in 2022, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.
Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. The high prevalence and outbreaks of infectious diseases and the high adoption of self-testing kits for infectious diseases are primary factors supporting the large market share of this segment.
Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. Factors attributing to this segment's growth include increasing hospitalizations due to various diseases, the increasing geriatric population, and increased healthcare access & expenditure.
An in-depth analysis of the geographical scenario of the rapid diagnostic kits market for Indian Ocean region countries provides detailed qualitative and quantitative insights about the major geographies (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, R?union, Comoros, Mayotte, and Seychelles). France is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022, followed by India, Australia, Indonesia, and Singapore.
Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioM?rieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Scope of the Report
Scope of the Report
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product
- Professional Kits
- OTC Kits
- Immunoassays
- Molecular Detection
- Other Rapid Diagnostic Platforms
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application
- Infectious Diseases Testing
- Pregnancy And Fertility Testing
- Cardiac Metabolism Testing
- Cholesterol Testing
- Tumor/Cancer Markers Testing
- Blood Glucose Testing
- Urinalysis
- Hematology Testing
- Other Tests
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care/Self-testing
- Other End Users
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography
- France
- India
- Australia
- Indonesia
- Singapore
- Sri Lanka
- Madagascar
- Mauritius
- Reunion
- Mayotte
- Seychelles
- Comoros
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
4.2.4. The Outbreak of the COVID-19 Pandemic
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region
4.5. Challenges
4.5.1. Reluctance toward Changing Existing Diagnostic Practices
4.6. Rapid Diagnostics: Innovations & Upcoming Technologies
5. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY PRODUCT
5.1. Introduction
5.2. Professional Kits
5.3. OTC Kits
6. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY PLATFORM
6.1. Introduction
6.2. Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms
7. RAPID DIAGNOSTIC KITS MARKET FOR INDIAN OCEAN REGION COUNTRIES, BY APPLICATION
7.1. Introduction
7.2. Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests
8. RAPID DIAGNOSTIC KITS MARKET FOR INDIAN OCEAN REGION COUNTRIES, BY END USER
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users
9. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY GEOGRAPHY
9.1. Introduction
9.2. France
9.3. India
9.4. Australia
9.5. Indonesia
9.6. Singapore
9.7. Sri Lanka
9.8. Madagascar
9.9. Mauritius
9.10. R?union
9.11. Mayotte
9.12. Seychelles
9.13. Comoros
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
11. COMPANY PROFILES (BUSINESS OVERVIEW, FINANCIAL OVERVIEW, PRODUCT PORTFOLIO, STRATEGIC DEVELOPMENTS)
11.1. Abbott Laboratories (U.S.)
11.2. Becton, Dickinson and Company (BD) (U.S.)
11.3. Bio-Rad Laboratories, Inc. (U.S.)
11.4. F. Hoffmann-La Roche Ltd (Switzerland)
11.5. ACON Laboratories, Inc. (U.S.)
11.6. Danaher Corporation (U.S.)
11.7. Thermo Fisher Scientific Inc. (U.S.)
11.8. bioM?rieux S.A. (France)
11.9. Alfa Scientific Designs, Inc. (U.S.)
11.10. BTNX Inc. (Canada)
11.11. Meridian Bioscience, Inc. (U.S.)
11.12. Trinity Biotech plc (Ireland)
12. APPENDIX
12.1. Questionnaire
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
4.2.4. The Outbreak of the COVID-19 Pandemic
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region
4.5. Challenges
4.5.1. Reluctance toward Changing Existing Diagnostic Practices
4.6. Rapid Diagnostics: Innovations & Upcoming Technologies
5. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY PRODUCT
5.1. Introduction
5.2. Professional Kits
5.3. OTC Kits
6. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY PLATFORM
6.1. Introduction
6.2. Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms
7. RAPID DIAGNOSTIC KITS MARKET FOR INDIAN OCEAN REGION COUNTRIES, BY APPLICATION
7.1. Introduction
7.2. Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests
8. RAPID DIAGNOSTIC KITS MARKET FOR INDIAN OCEAN REGION COUNTRIES, BY END USER
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users
9. RAPID DIAGNOSTIC KITS MARKET IN INDIAN OCEAN REGION COUNTRIES, BY GEOGRAPHY
9.1. Introduction
9.2. France
9.3. India
9.4. Australia
9.5. Indonesia
9.6. Singapore
9.7. Sri Lanka
9.8. Madagascar
9.9. Mauritius
9.10. R?union
9.11. Mayotte
9.12. Seychelles
9.13. Comoros
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
11. COMPANY PROFILES (BUSINESS OVERVIEW, FINANCIAL OVERVIEW, PRODUCT PORTFOLIO, STRATEGIC DEVELOPMENTS)
11.1. Abbott Laboratories (U.S.)
11.2. Becton, Dickinson and Company (BD) (U.S.)
11.3. Bio-Rad Laboratories, Inc. (U.S.)
11.4. F. Hoffmann-La Roche Ltd (Switzerland)
11.5. ACON Laboratories, Inc. (U.S.)
11.6. Danaher Corporation (U.S.)
11.7. Thermo Fisher Scientific Inc. (U.S.)
11.8. bioM?rieux S.A. (France)
11.9. Alfa Scientific Designs, Inc. (U.S.)
11.10. BTNX Inc. (Canada)
11.11. Meridian Bioscience, Inc. (U.S.)
11.12. Trinity Biotech plc (Ireland)
12. APPENDIX
12.1. Questionnaire
LIST OF TABLES
Table 1 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Drivers (2022–2029)
Table 2 Estimated Number of New Cancer Cases, by Country (2020 VS. 2030)
Table 3 Number of People Living with Diabetes, by Country (2011 VS. 2021 VS. 2030)
Table 4 Number of People Aged 65 Years and Above, by Country, 2019 VS. 2030
Table 5 Adults and Children Living with HIV, by Country (2021)
Table 6 Prevalence of COVID-19, by Country
Table 7 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Restraints (2022–2029)
Table 8 GDP Per Capita of Some of the Countries in the Indian Ocean Region
Table 9 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Product, 2020–2029 (USD Million)
Table 10 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Professional Kits, by Country/Region, 2020–2029 (USD Million)
Table 11 No. of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 12 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for OTC Kits, by Country/Region, 2020–2029 (USD Million)
Table 13 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2020–2029 (USD Million)
Table 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Immunoassays, by Country/Region, 2020–2029 (USD Million)
Table 15 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries Molecular Detection Tests, by Country/Region, 2020–2029 (USD Million)
Table 16 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Other Rapid Diagnostic Platforms, by Country/Region, 2020–2029 (USD Million)
Table 17 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2020–2029 (USD Million)
Table 18 Rapid Diagnostic Kits Market Size for Infectious Disease Testing, by Country/Region, 2020–2029 (USD Million)
Table 19 Rapid Diagnostic Kits Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million)
Table 20 Deaths From Cardiovascular Diseases in Singapore (2019–2021)
Table 21 Rapid Diagnostic Kits Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million)
Table 22 Rapid Diagnostic Kits Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million)
Table 23 Rapid Diagnostic Kits Market Size for Tumor/Cancer Testing, by Country/Region, 2020–2029 (USD Million)
Table 24 Number of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 25 Rapid Diagnostic Kits Market Size for Blood Glucose Testing, by Country/Region, 2020–2029 (USD Million)
Table 26 Rapid Diagnostic Kits Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 27 Anemia Prevalence India (2014–2015 VS. 2019–2021)
Table 28 Rapid Diagnostic Kits Market Size for Hematology, by Country/Region, 2020–2029 (USD Million)
Table 29 Rapid Diagnostic Kits Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million)
Table 30 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2020–2029 (USD Million)
Table 31 Rapid Diagnostic Kits Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million)
Table 32 Rapid Diagnostic Kits Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 33 Population Aged 65 and Above, Total Number (2021)
Table 34 Rapid Diagnostic Kits Market Size for Home Care/Self-testing, by Country/Region, 2020–2029 (USD Million)
Table 35 Rapid Diagnostic Kits Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 36 Rapid Diagnostic Kits Market in Indian Ocean Region Countries Size, by Country, 2020–2029 (USD Million)
Table 37 France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 38 France: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 39 France: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 40 France: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 41 Recent Initiatives Launched by the Government of India to Combat the COVID–19 Pandemic
Table 42 India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 43 India: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 44 India: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 45 India: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 46 Australia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 47 Australia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 48 Australia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 49 Australia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 50 Indonesia: Tuberculosis Statistics
Table 51 Indonesia: HIV Statistics (2021)
Table 52 Indonesia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 53 Indonesia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 54 Indonesia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 55 Indonesia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 56 Singapore: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 57 Singapore: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 58 Singapore: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 59 Singapore: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 60 Sri Lanka: Leading Causes of Hospital Deaths (2019)
Table 61 Sri Lanka: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 62 Sri Lanka: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 63 Sri Lanka: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 64 Sri Lanka: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 65 Madagascar: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 66 Madagascar: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 67 Madagascar: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 68 Madagascar: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 69 Mauritius: Leading Causes of Death
Table 70 Recent Developments, by Company, 2019–2022
Table 1 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Drivers (2022–2029)
Table 2 Estimated Number of New Cancer Cases, by Country (2020 VS. 2030)
Table 3 Number of People Living with Diabetes, by Country (2011 VS. 2021 VS. 2030)
Table 4 Number of People Aged 65 Years and Above, by Country, 2019 VS. 2030
Table 5 Adults and Children Living with HIV, by Country (2021)
Table 6 Prevalence of COVID-19, by Country
Table 7 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Restraints (2022–2029)
Table 8 GDP Per Capita of Some of the Countries in the Indian Ocean Region
Table 9 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Product, 2020–2029 (USD Million)
Table 10 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Professional Kits, by Country/Region, 2020–2029 (USD Million)
Table 11 No. of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 12 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for OTC Kits, by Country/Region, 2020–2029 (USD Million)
Table 13 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2020–2029 (USD Million)
Table 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Immunoassays, by Country/Region, 2020–2029 (USD Million)
Table 15 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries Molecular Detection Tests, by Country/Region, 2020–2029 (USD Million)
Table 16 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Other Rapid Diagnostic Platforms, by Country/Region, 2020–2029 (USD Million)
Table 17 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2020–2029 (USD Million)
Table 18 Rapid Diagnostic Kits Market Size for Infectious Disease Testing, by Country/Region, 2020–2029 (USD Million)
Table 19 Rapid Diagnostic Kits Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million)
Table 20 Deaths From Cardiovascular Diseases in Singapore (2019–2021)
Table 21 Rapid Diagnostic Kits Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million)
Table 22 Rapid Diagnostic Kits Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million)
Table 23 Rapid Diagnostic Kits Market Size for Tumor/Cancer Testing, by Country/Region, 2020–2029 (USD Million)
Table 24 Number of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 25 Rapid Diagnostic Kits Market Size for Blood Glucose Testing, by Country/Region, 2020–2029 (USD Million)
Table 26 Rapid Diagnostic Kits Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 27 Anemia Prevalence India (2014–2015 VS. 2019–2021)
Table 28 Rapid Diagnostic Kits Market Size for Hematology, by Country/Region, 2020–2029 (USD Million)
Table 29 Rapid Diagnostic Kits Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million)
Table 30 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2020–2029 (USD Million)
Table 31 Rapid Diagnostic Kits Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million)
Table 32 Rapid Diagnostic Kits Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 33 Population Aged 65 and Above, Total Number (2021)
Table 34 Rapid Diagnostic Kits Market Size for Home Care/Self-testing, by Country/Region, 2020–2029 (USD Million)
Table 35 Rapid Diagnostic Kits Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 36 Rapid Diagnostic Kits Market in Indian Ocean Region Countries Size, by Country, 2020–2029 (USD Million)
Table 37 France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 38 France: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 39 France: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 40 France: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 41 Recent Initiatives Launched by the Government of India to Combat the COVID–19 Pandemic
Table 42 India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 43 India: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 44 India: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 45 India: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 46 Australia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 47 Australia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 48 Australia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 49 Australia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 50 Indonesia: Tuberculosis Statistics
Table 51 Indonesia: HIV Statistics (2021)
Table 52 Indonesia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 53 Indonesia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 54 Indonesia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 55 Indonesia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 56 Singapore: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 57 Singapore: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 58 Singapore: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 59 Singapore: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 60 Sri Lanka: Leading Causes of Hospital Deaths (2019)
Table 61 Sri Lanka: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 62 Sri Lanka: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 63 Sri Lanka: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 64 Sri Lanka: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 65 Madagascar: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 66 Madagascar: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 67 Madagascar: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 68 Madagascar: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 69 Mauritius: Leading Causes of Death
Table 70 Recent Developments, by Company, 2019–2022
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 8 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 9 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Application, 2022 VS. 2029 (USD Million)
Figure 10 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022 VS. 2029 (USD Million)
Figure 11 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Country, 2022 VS. 2029
Figure 12 Market Dynamics
Figure 13 Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 15 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2022 VS. 2029 (USD Million)
Figure 16 Deaths Due to Heart Attacks in India (2017–2020)
Figure 17 Estimated Number of New Cancer Cases in Some of the Countries of the Indian Ocean Region, 2020–2030
Figure 18 Prevalence of Impaired Glucose Tolerance in India & Indonesia (2019–2045) (Million)
Figure 19 Estimated Number of New Leukemia Cases in Some of the Countries in the Indian Ocean Region (2020–2030)
Figure 20 Estimated Number of New Colon Cancer Cases in Some of the Indian Ocean Region Countries (2020 VS. 2030)
Figure 21 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022–2029 (USD Million)
Figure 22 Healthcare Expenditure Per Capita, Purchasing Power Parities (PPP), (USD), 2019
Figure 23 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Country, 2022–2029 (USD Million)
Figure 24 France: Percentage of Population Aged 65 Years and Above, 2016–2020
Figure 25 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
Figure 26 France: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 27 India: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 28 Australia: Most Prevalent Chronic Diseases (2020–2021) (% of Total Population)
Figure 29 Australia: Infectious Disease Cases, in Thousand (2017–2021)
Figure 30 Australia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 31 Indonesia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 32 Singapore: Number of Deaths Due to Diseases (% of Total Population) (2019–2020)
Figure 33 Singapore: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 34 Sri Lanka: Government Health Expenditure (2017–2019)
Figure 35 Sri Lanka: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 36 Madagascar: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 37 Mauritius: Deaths Per 100,000 People Due to Ncd (2017–2020)
Figure 38 Mauritius: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 39 R?union: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 40 Mayoytte: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 41 Seychelles: Number of People Aged 65 Years and Above
Figure 42 Seychelles: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 43 Comoros: Number of People Aged 65 Years and Above (2015–2021)
Figure 44 Comoros: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 45 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 46 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Competitive Benchmarking, by Platform
Figure 47 Abbott Laboratories: Financial Overview (2021)
Figure 48 Becton, Dickinson and Company: Financial Overview (2021)
Figure 49 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 50 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 51 Danaher Corporation: Financial Overview (2021)
Figure 52 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 53 bioM?rieux S.A.: Financial Overview (2021)
Figure 54 Meridian Bioscience, Inc.: Financial Overview (2021)
Figure 55 Trinity Biotech plc: Financial Overview (2021)
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 8 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 9 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Application, 2022 VS. 2029 (USD Million)
Figure 10 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022 VS. 2029 (USD Million)
Figure 11 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Country, 2022 VS. 2029
Figure 12 Market Dynamics
Figure 13 Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 15 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2022 VS. 2029 (USD Million)
Figure 16 Deaths Due to Heart Attacks in India (2017–2020)
Figure 17 Estimated Number of New Cancer Cases in Some of the Countries of the Indian Ocean Region, 2020–2030
Figure 18 Prevalence of Impaired Glucose Tolerance in India & Indonesia (2019–2045) (Million)
Figure 19 Estimated Number of New Leukemia Cases in Some of the Countries in the Indian Ocean Region (2020–2030)
Figure 20 Estimated Number of New Colon Cancer Cases in Some of the Indian Ocean Region Countries (2020 VS. 2030)
Figure 21 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022–2029 (USD Million)
Figure 22 Healthcare Expenditure Per Capita, Purchasing Power Parities (PPP), (USD), 2019
Figure 23 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Country, 2022–2029 (USD Million)
Figure 24 France: Percentage of Population Aged 65 Years and Above, 2016–2020
Figure 25 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
Figure 26 France: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 27 India: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 28 Australia: Most Prevalent Chronic Diseases (2020–2021) (% of Total Population)
Figure 29 Australia: Infectious Disease Cases, in Thousand (2017–2021)
Figure 30 Australia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 31 Indonesia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 32 Singapore: Number of Deaths Due to Diseases (% of Total Population) (2019–2020)
Figure 33 Singapore: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 34 Sri Lanka: Government Health Expenditure (2017–2019)
Figure 35 Sri Lanka: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 36 Madagascar: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 37 Mauritius: Deaths Per 100,000 People Due to Ncd (2017–2020)
Figure 38 Mauritius: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 39 R?union: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 40 Mayoytte: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 41 Seychelles: Number of People Aged 65 Years and Above
Figure 42 Seychelles: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 43 Comoros: Number of People Aged 65 Years and Above (2015–2021)
Figure 44 Comoros: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 45 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 46 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Competitive Benchmarking, by Platform
Figure 47 Abbott Laboratories: Financial Overview (2021)
Figure 48 Becton, Dickinson and Company: Financial Overview (2021)
Figure 49 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 50 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 51 Danaher Corporation: Financial Overview (2021)
Figure 52 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 53 bioM?rieux S.A.: Financial Overview (2021)
Figure 54 Meridian Bioscience, Inc.: Financial Overview (2021)
Figure 55 Trinity Biotech plc: Financial Overview (2021)
